TRANSDERMAL DELIVERY SYSTEM
A transdermal delivery system comprising one or more permeation enhancers and a compound selected from the group consisting of tiagabine, pharmaceutically acceptable salts or pharmaceutically acceptable C1-6-alkylesters thereof and ionpairs of tiagabine and salicylic or oleic acid, wherein the penet...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slo |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | A transdermal delivery system comprising one or more permeation enhancers and a compound selected from the group consisting of tiagabine, pharmaceutically acceptable salts or pharmaceutically acceptable C1-6-alkylesters thereof and ionpairs of tiagabine and salicylic or oleic acid, wherein the penetration enhancer is selected from the group consisting of saturated and unsaturated fatty acids and esters thereof in propylene glycol, bisabolol in ethanol/water. cineol in ethanol/water, hydroxypropyl-beta-cyclodextrin in ethanol/water or decylmethylsulfoxide in ethanol/water. The delivery system is useful in the treatment of epilepsy.
Systém obsahuje jednu alebo viac zlúčenín na zvýšenie permeácie vybraných, zo skupiny zahrňujúcej nasýtené a nenasýtené mastné kyseliny a ich estery v propylénglykole, bisabololu v etanol/vode, cineolu v etanol/vode, hydroxypropyl-D- -cyklodextrínu v etanol/vode alebo decylmetylsulfoxidu v etanol/vode a zlúčeninu vybranú z tiagabínu, jeho farmaceuticky prijateľných solí, farmaceuticky prijateľných C1-6-alkylesterov alebo iónových párov tiagabínu a kyseliny salicylovej alebo olejovej. Tento transdermálny dodávací systém je vhodný na liečenie epilepsie.ŕ |
|---|